Results 101 to 110 of about 34,967 (216)

Rivaroxaban for thromboprophylaxis after hospitalization for medical illness

, 2018
BACKGROUND Patients who are hospitalized for medical illness remain at risk for venous thromboembolism after discharge, but the role of extended thromboprophylaxis in the treatment of such patients is a subject of controversy. METHODS In this randomized,
Spyropoulos, AC, Steg, PG, Maynard, GA, Suh, E, Ageno, W, Albers, GW, Barnathan, ES, Hiatt, WR, Weitz, JI, Halperin, JL, Elliott, CG, Spiro, TE, Raskob, GE, Sabet, A, et al.   +14 more
core   +1 more source

The impact of body weight on rivaroxaban pharmacokinetics [PDF]

, 2017
EssentialsThe optimal dosing strategy of rivaroxaban for patients at the extremes of body weight is not known.A pharmacokinetic study was conducted based in real-world patients in a London teaching hospital.In the cohort of patients studied, weight on ...
Jignesh P. Patel, Roberts, Lara, Roopen Arya, Green, Bruce, Sarah J. Barsam, Patel, Rajesh, Venu Kavarthapu, Lara N. Roberts, Kavarthapu, Venu, Bruce Green, Barsam, Sarah Joy, Patel, Jignesh Prakash; id_orcid, Arya, Roopen, Raj K. Patel   +13 more
core   +1 more source

Rivaroxaban [PDF]

pharma-kritik, 2009
Ein direkter Hemmer von Faktor-Xa, der oral verabreicht werden kann. Dieses Antikoagulans ist bisher zur Thromboembolie-Prophylaxe nach grossen orthopädischen Eingriffen zugelassen. Sein Nutzen/Risiko-Profil ist noch ungenügend definiert.
openaire   +1 more source

Pregnancy Complicated by Hereditary Antithrombin Deficiency: A Case Study and Insights From the Literature

Clinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT A pregnant woman with hereditary antithrombin deficiency was managed with adjusted‐dose LMWH throughout pregnancy, monitoring D‐dimer and anti‐Xa activity, successfully preventing thrombosis and hemorrhage.
Ya Zhao, Jian Yin, Jia Song, Yuqi Zhao, Yanping Zhang   +4 more
wiley   +1 more source

Rivaroxaban [díptic]

, 2018
Anticoagulants orals d’acció directa; Rivaroxaban; MedicamentsAnticoagulantes orales de acción directa; Rivaroxaban; MedicamentosDirect-acting oral anticoagulants; Rivaroxaban; MedicinesPreguntes i respostes sobre l’anticoagulant oral d’acció directa ...

core  

A Case of Rivaroxaban Associated Intracranial Hemorrhage [PDF]

, 2014
Rivaroxaban is a newer anticoagulant initially approved by the Food and Drug Administration to treat nonvalvular atrial fibrillation. Rivaroxaban has several characteristics that are more favorable than warfarin.
Lo, Jean CY, Roy R. Gerona, Gerona, Roy R, Jean Chin-Yu Lo   +3 more
core   +1 more source

In Vivo pharmacokinetic interactions of ribociclib with rivaroxaban and apixaban in rats: implications for increased drug exposure and dose adjustments

Frontiers in Pharmacology
BackgroundApixaban (API) and rivaroxaban (RIVA) are orally available inhibitors of coagulation factor Xa and are commonly used to treat cancer-related venous thrombosis.
Zihan Liu, Zihan Liu, Wenyu Du, Wenyu Du, Qimin Wang, Zhi Wang, Jing An, Yinling Ma, Zhanjun Dong, Ying Li   +9 more
doaj   +1 more source

Thrombus‐Induced Prosthetic Valve Dysfunction Demonstrating Hypo‐Attenuated Leaflet Thickening: A Case Report

Clinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Hypo‐attenuated leaflet thickening (HALT) is an important and potentially underrecognized cause of late bioprosthetic valve dysfunction after surgical AVR. Multimodal imaging, including echocardiography and electrocardiogram‐gated computed tomography, is essential for diagnosis, and timely surgical or medical intervention can effectively ...
Takanori Kono, Kazuyoshi Takagi, Yusuke Shintani, Hiroki Mine, Eiki Tayama   +4 more
wiley   +1 more source

Rivaroxaban alleviates hepatic sinusoidal obstruction syndrome in mice by modulating the gut microbiota and inhibiting the PI3K/Akt signaling pathway

Frontiers in Microbiology
IntroductionHepatic sinusoidal obstruction syndrome (HSOS) is a vascular liver disease with a high mortality rate, and treatment methods are limited. Rivaroxaban is an oral anticoagulant.
Wencheng Liu, Yanbin Cheng, Xue Han, Junlin Xia, Qingyu Wei, Bing Chang, Quansheng Li   +6 more
doaj   +1 more source

Rivaroxaban for venous thromboembolism prevention after major orthopedic surgery: translating trial data into routine clinical practice

, 2017
Jan Beyer-Westendorf,1 Patrick Mouret,2 Alexander GG Turpie3 1Thrombosis Research and Angiology, Dresden University Clinic, Dresden, Germany; 2Orthopedic Clinic, Klinikum Frankfurt Höchst GmbH, Frankfurt, Germany; 3Department of Medicine, General ...
Mouret P, Turpie AGG, Beyer-Westendorf J
core